Yahoo
NasdaqGS - Delayed Quote USD

Utah Medical Products, Inc. (UTMD)

66.80 -2.04 (-2.96%)
At close: 4:00:00 PM EDT
Trade UTMD on Coinbase
Chart Range Bar
Loading chart for UTMD
  • Previous Close 68.84
  • Open 69.16
  • Bid 49.68 x 200
  • Ask 85.87 x 200
  • Day's Range 66.65 - 69.92
  • 52 Week Range 53.66 - 76.89
  • Volume 32,558
  • Avg. Volume 35,175
  • Market Cap (intraday) 212.09M
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) 20.00
  • EPS (TTM) 3.34
  • Earnings Date Oct 22, 2026
  • Forward Dividend & Yield 1.24 (1.80%)
  • Ex-Dividend Date Sep 17, 2026
  • 1y Target Est --

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

www.utahmed.com

140

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

UTMD
21.01%
S&P 500 (^GSPC)
12.78%

1-Year Return

UTMD
19.41%
S&P 500 (^GSPC)
12.04%

3-Year Return

UTMD
8.30%
S&P 500 (^GSPC)
87.51%

5-Year Return

UTMD
23.94%
S&P 500 (^GSPC)
67.64%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY14
Revenue 9.83M
Earnings 2.72M
Profit Margin 27.70%

Q2

FY13

Q3

FY13

Q4

FY13

Q1

FY14

0
2M
4M
6M
8M
10M
26.0%
28.0%
30.0%
32.0%
34.0%

Statistics

View More

Valuation Measures

Annual
As of 10/28/2026
  • Market Cap

    218.54M

  • Enterprise Value

    133.51M

  • Trailing P/E

    21.88

  • Forward P/E

    --

  • PEG Ratio (current)

    7.37

  • Price/Sales (ttm)

    6.66

  • Price/Book (mrq)

    1.88

  • Enterprise Value/Revenue

    3.82

  • Enterprise Value/EBITDA

    8.70

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    30.48%

  • Return on Assets (ttm)

    5.97%

  • Return on Equity (ttm)

    8.81%

  • Revenue (ttm)

    34.92M

  • Net Income Avi to Common (ttm)

    10.64M

  • Diluted EPS (ttm)

    3.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    85.2M

  • Total Debt/Equity (mrq)

    0.15%

  • Levered Free Cash Flow (ttm)

    --

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

66.80 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: